180 Life Sciences Stock Annual Yield
| ATNF Stock | USD 3.54 0.26 7.93% |
Fundamental analysis of 180 Life allows traders to better anticipate movements in 180 Life's stock price by examining its financial health and performance throughout various phases of its business cycle.
180 | Annual Yield | Build AI portfolio with 180 Stock |
180 Life Sciences Company Annual Yield Analysis
180 Life's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
180 Annual Yield Driver Correlations
Understanding the fundamental principles of building solid financial models for 180 Life is extremely important. It helps to project a fair market value of 180 Stock properly, considering its historical fundamentals such as Annual Yield. Since 180 Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of 180 Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of 180 Life's interrelated accounts and indicators.
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, 180 Life Sciences has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
180 Life ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, 180 Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to 180 Life's managers, analysts, and investors.Environmental | Governance | Social |
180 Fundamentals
| Return On Equity | -3.71 | ||||
| Return On Asset | -0.55 | ||||
| Current Valuation | 19.97 M | ||||
| Shares Outstanding | 6.04 M | ||||
| Shares Owned By Insiders | 47.89 % | ||||
| Shares Owned By Institutions | 1.03 % | ||||
| Number Of Shares Shorted | 63.95 K | ||||
| Price To Earning | 0.63 X | ||||
| Price To Book | 3.86 X | ||||
| EBITDA | (6.32 M) | ||||
| Net Income | (6.17 M) | ||||
| Cash And Equivalents | 1.63 M | ||||
| Cash Per Share | 0.04 X | ||||
| Total Debt | 154.5 K | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 0.67 X | ||||
| Book Value Per Share | 0.89 X | ||||
| Cash Flow From Operations | (1.48 M) | ||||
| Short Ratio | 0.81 X | ||||
| Earnings Per Share | (14.95) X | ||||
| Target Price | 80.0 | ||||
| Beta | 0.24 | ||||
| Market Capitalization | 21.38 M | ||||
| Total Asset | 12.76 M | ||||
| Retained Earnings | (141.52 M) | ||||
| Working Capital | 1.64 M | ||||
| Net Asset | 12.76 M |
About 180 Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 180 Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 180 Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 180 Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Check out 180 Life Piotroski F Score and 180 Life Altman Z Score analysis. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 180 Life. If investors know 180 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 180 Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of 180 Life Sciences is measured differently than its book value, which is the value of 180 that is recorded on the company's balance sheet. Investors also form their own opinion of 180 Life's value that differs from its market value or its book value, called intrinsic value, which is 180 Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 180 Life's market value can be influenced by many factors that don't directly affect 180 Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 180 Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if 180 Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 180 Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.